{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:45:54Z","timestamp":1790390754070,"version":"4.1.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Concentrations of 6-thioguanine (6TG) nucleotides and 6-methylmercaptopurine (6MMP) nucleotides in RBCs were measured using liquid chromatography-tandem mass spectrometry (LC-MS\/MS). This assay was validated for clinical use and was applied to blood samples from patients taking mercaptopurine (6MP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>RBCs were hemolyzed and deproteinized using perchloric acid, followed by heating for the hydrolysis of nucleotides, and the resultant base was measured using LC-MS\/MS. Precision, recovery, linearity, matrix effect, and limit of quantification was validated for clinical application. Our results were compared with another institution's established LC-MS\/MS assay. We measured the concentrations of 6TG and 6MMP in RBCs of pediatric patients with acute lymphoblastic leukemia (ALL), and the clinical impact of those metabolites was investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The imprecision coefficient of variations of 6TG and 6MMP were 5.7%\u20138.1%, and the bias was within 5%. Lower limits of quantification were set at 54 ng\/mL for 6TG and 1036 ng\/mL for 6MMP. Correlation coefficients for 6TG and 6MMP were 0.997 and 1.0 in a comparison study. For clinical proof-of-concept, 74 blood samples were collected from 37 pediatric ALL patients receiving maintenance therapy. Concentration of 6TG ranged from 16.1 to 880 pmol\/8 \u00d7 10<jats:sup>8<\/jats:sup> RBCs and that of 6MMP from 55 to 20,937 pmol\/8 \u00d7 10<jats:sup>8<\/jats:sup> RBCs. The 6MP metabolites were not correlated with WBC or absolute neutrophil count. On the other hand, the higher 6MMP level was associated with elevated alanine aminotransferase and aspartate aminotransferase.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In this study, an assay for the quantification of 6TG and 6MMP in RBCs was established and applied to pediatric ALL patients. Interindividual variability in 6MP metabolite concentrations was considerable and associated with elevation of liver enzymes, which may be useful in the clinical monitoring of 6MP maintenance therapy in pediatric ALL patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000575","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T20:26:19Z","timestamp":1543609579000},"page":"75-85","source":"Crossref","is-referenced-by-count":10,"title":["Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"41","author":[{"given":"Soo Young","family":"Moon","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University College of Medicine;"},{"name":"Institute of Biomedical Research, Seoul National University College of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyun","family":"Lim","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research, Seoul National University College of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Hee","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research, Seoul National University College of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngwon","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University College of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Therapeutics;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Taek","family":"Hong","sequence":"additional","affiliation":[{"name":"Pediatrics, Seoul National University College of Medicine;"},{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Yoon","family":"Choi","sequence":"additional","affiliation":[{"name":"Pediatrics, Seoul National University College of Medicine;"},{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che Ry","family":"Hong","sequence":"additional","affiliation":[{"name":"Pediatrics, Seoul National University College of Medicine;"},{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyery","family":"Kim","sequence":"additional","affiliation":[{"name":"Pediatrics, Seoul National University College of Medicine;"},{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Jin","family":"Kang","sequence":"additional","affiliation":[{"name":"Pediatrics, Seoul National University College of Medicine;"},{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Young","family":"Shin","sequence":"additional","affiliation":[{"name":"Pediatrics, Seoul National University College of Medicine;"},{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyunghoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Youn","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University College of Medicine;"},{"name":"Institute of Biomedical Research, Seoul National University College of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MPH.0000000000000206","article-title":"Mercaptopurine\/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia\u202f: clinical facts and fiction","volume":"36","author":"Schmiegelow","year":"2014","journal-title":"J Pediatr Hematol Oncol."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc2292","article-title":"Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer","volume":"8","author":"Karran","year":"2008","journal-title":"Nat Rev Cancer."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/clpt.2013.4","article-title":"Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update","volume":"93","author":"Relling","year":"2013","journal-title":"Clin Pharmacol Ther."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0022-3476(05)83063-X","article-title":"Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia","volume":"119","author":"Evans","year":"1991","journal-title":"J Pediatr."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia","volume":"336","author":"Lennard","year":"1990","journal-title":"Lancet."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/clinchem\/46.11.1728","article-title":"Genotyping of eight thiopurine methyltransferase mutations: three-color multiplexing, \u201ctwo-color\/shared\u201d anchor, and fluorescence-quenching hybridization probe assays based on thermodynamic nearest-neighbor probe design","volume":"46","author":"Schutz","year":"2000","journal-title":"Clin Chem."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","article-title":"Modern therapy of acute lymphoblastic leukemia","volume":"29","author":"Bassan","year":"2011","journal-title":"J Clin Oncol."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaoncol.2015.0245","article-title":"Systemic exposure to thiopurines and risk of relapse in children with acute lymphoblastic leukemia: a children\u2019s oncology group study","volume":"1","author":"Bhatia","year":"2015","journal-title":"JAMA Oncol."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1182\/blood-2008-11-187880","article-title":"Methotrexate\/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study","volume":"113","author":"Schmiegelow","year":"2009","journal-title":"Blood."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00685079","article-title":"Methotrexate and 6-mercaptopurine maintenance therapy for childhood acute lymphoblastic leukemia: dose adjustments by white cell counts or by pharmacokinetic parameters?","volume":"34","author":"Schmiegelow","year":"1994","journal-title":"Cancer Chemother Pharmacol."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V92.10.3569","article-title":"Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children\u2019s cancer group and pediatric oncology branch study","volume":"92","author":"Balis","year":"1998","journal-title":"Blood."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0140-6736(94)92400-7","article-title":"Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia","volume":"343","author":"Lilleyman","year":"1994","journal-title":"Lancet."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1200\/JCO.1995.13.2.345","article-title":"Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy","volume":"13","author":"Schmiegelow","year":"1995","journal-title":"J Clin Oncol."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/adc.76.4.365","article-title":"Profile of non-compliance in lymphoblastic leukaemia","volume":"76","author":"Lancaster","year":"1997","journal-title":"Arch Dis Child."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1373\/clinchem.2005.050831","article-title":"Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine\/6-mercaptopurine therapy","volume":"51","author":"Dervieux","year":"2005","journal-title":"Clin Chem."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00280-009-1184-5","article-title":"DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma","volume":"66","author":"Hedeland","year":"2010","journal-title":"Cancer Chemother Pharmacol."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.clpt.2003.12.001","article-title":"Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity","volume":"75","author":"Nygaard","year":"2004","journal-title":"Clin Pharmacol Ther."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.2042-7158.1983.tb04255.x","article-title":"Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells","volume":"35","author":"Lennard","year":"1983","journal-title":"J Pharm Pharmacol."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1373\/49.2.260","article-title":"Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods","volume":"49","author":"Shipkova","year":"2003","journal-title":"Clin Chem."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jchromb.2010.03.004","article-title":"Limited stability of thiopurine metabolites in blood samples: relevant in research and clinical practise","volume":"878","author":"de Graaf","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/44.3.551","article-title":"Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3343\/alm.2018.38.3.255","article-title":"Evaluation of stability of thiopurine metabolites using a validated LC-MS\/MS method","volume":"38","author":"Yoo","year":"2018","journal-title":"Ann Lab Med."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/MIB.0000000000000347","article-title":"Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine","volume":"21","author":"Lee","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817","article-title":"Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia","volume":"93","author":"Relling","year":"1999","journal-title":"Blood."},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(92)80347-S","article-title":"High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample","volume":"583","author":"Lennard","year":"1992","journal-title":"J Chromatogr B Biomed Sci Appl."},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/gut.39.3.401","article-title":"6-Mercaptopurine metabolism in Crohn\u2019s disease: correlation with efficacy and toxicity","volume":"39","author":"Cuffari","year":"1996","journal-title":"Gut."},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/FTD.0b013e318283ed5d","article-title":"Improved method for therapeutic drug monitoring of 6-thioguanine nucleotides and 6-methylmercaptopurine in whole-blood by LC\/MSMS using isotope-labeled internal standards","volume":"35","author":"Kirchherr","year":"2013","journal-title":"Ther Drug Monit."},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/ac2031699","article-title":"Simultaneous quantification of eleven thiopurine nucleotides by liquid chromatography-tandem mass spectrometry","volume":"84","author":"Hofmann","year":"2012","journal-title":"Anal Chem."},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3329\/icpj.v1i11.12059","article-title":"Simultaneous determination of azathioprine and its metabolite 6-mercaptopurine in human plasma using solid phase extraction-evaporation and liquid chromatography-positive electrospray tandem mass spectrometry","volume":"1","author":"Raja","year":"2012","journal-title":"Int Curr Pharm J."},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jchromb.2016.10.035","article-title":"Development and validation of LC\u2013MS\/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: correlation with genetic polymorphism","volume":"1038","author":"Al-Ghobashy","year":"2016","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci."},{"key":"R34-20230814","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0928-0987(99)00027-5","article-title":"Metabolites of mercaptopurine in red blood cells: a relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukemia","volume":"8","author":"Chrzanowska","year":"1999","journal-title":"Eur J Pharm Sci."},{"key":"R35-20230814","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/clinchem\/44.12.2511","article-title":"Identification of 6-methylmercaptopurine derivative formed during acid hydrolysis of thiopurine nucleotides in erythrocytes, using liquid chromatography-mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem."},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2125.2010.03867.x","article-title":"Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy","volume":"71","author":"Adam de Beaumais","year":"2011","journal-title":"Br J Clin Pharmacol."},{"key":"R37-20230814","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.2011.38.9924","article-title":"Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"30","author":"Bhatia","year":"2012","journal-title":"J Clin Oncol."},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/bjc.1995.450","article-title":"Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?","volume":"72","author":"Lennard","year":"1995","journal-title":"Br J Cancer."},{"key":"R39-20230814","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1200\/JCO.1989.7.12.1816","article-title":"Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia","volume":"7","author":"Lennard","year":"1989","journal-title":"J Clin Oncol."},{"key":"R40-20230814","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","article-title":"Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia","volume":"85","author":"McLeod","year":"1995","journal-title":"Blood."},{"key":"R41-20230814","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00008571-199510000-00003","article-title":"Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults","volume":"5","author":"McLeod","year":"1995","journal-title":"Pharmacogenetics."},{"key":"R42-20230814","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/clpt.1986.178","article-title":"Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrations","volume":"40","author":"Lennard","year":"1986","journal-title":"Clin Pharmacol Ther."},{"key":"R43-20230814","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF02897232","article-title":"6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia","volume":"26","author":"Schmiegelow","year":"1990","journal-title":"Cancer Chemother Pharmacol."},{"key":"R44-20230814","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1373\/clinchem.2007.086215","article-title":"6-Thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active Crohn disease: results from a randomized, controlled, open trial","volume":"53","author":"Reinshagen","year":"2007","journal-title":"Clin Chem."},{"key":"R45-20230814","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201902000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:15:07Z","timestamp":1692051307000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201902000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000575","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}